Cambridge Cancer Genomics Inc. (CCG.ai)

https://www.ccg.ai

Cambridge Cancer Genomics (CCG.ai) is a Y Combinator backed startup building the underlying tools to empower oncologists to make the best therapeutic decisions for their patients. Their precision AI platform, OncOS, is fast becoming the global open standard for next generation sequencing analysis and clinical decision support in cancer medicine. By focussing on machine learning based analytics of serial liquid biopsy samples, CCG.ai is building predictive models to understand how tumors evolve and how this can impact on response to therapy. As this knowledge base of tumour genomic evolution increases, OncOS will become the operating system for personalised cancer medicine. At CCG.ai, our mission is to ensure every patient gets the right drug, at the right time, to beat their cancer. *

	Start	2017-01-25 existent
	Group	Dante Genomics (Group)
	Industry	genomic software tools
	Industry 2	liquid biopsy

	Region	Cambridge, Cambridgeshire
	Country	United Kingdom (GB)
	Street	251 Little Falls Drive New Castle Country
	City	19808 Wilmington, DE
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Cambridge Cancer Genomics Ltd.. (3/21/19). "Press Release: Genomics England and Cambridge Cancer Genomics (CCG.ai) Announce Immunotherapy Partnership". Cambridge.

		Record changed: 2021-12-29